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E-CIGARETTE REGULATION IN CHINA: THE ROAD AHEAD
Eric A. Feldman,* Chai Yue†

The global electronic cigarette industry has exploded in the
past decade—from $20 million in sales in 2008 to an estimated $7
billion in 2014—and China has been an essential part of that growth.1
As the world's largest consumer of combustible tobacco products,
accounting for about one-third of the global market. China is also a
prime contender to become the largest consumer of electronic
cigarettes. These simple facts raise a critical question—what should
the Chinese government do about regulating electronic cigarettes?
So far, the regulation of electronic cigarettes in China has
attracted scant attention. 2 This paper begins to fill that gap by
identifying the key issues confronting regulators in China and
suggesting a way forward. It first describes the origin and
development of e-cigarettes in China and then discusses the current
regulatory status of e-cigarettes. Because two of the key regulatory
options Chinese regulators are likely to consider—treating electronic
cigarettes as tobacco products or as pharmaceutical products—
represent the approaches of the United States and Japan respectively,
the paper discusses e-cigarette regulation in those countries and
analyzes its relevance to China. The paper concludes by suggesting
that regardless of whether Chinese regulators decide to treat ecigarettes as tobacco products or pharmaceuticals, there are a
number of areas that invite immediate regulatory action. They
include the dubious health claims made by many e-cigarette
companies, such as suggesting that e-cigarettes are good for one’s
*

Eric A. Feldman, JD, PhD, Professor of Law, University of Pennsylvania Law School.
Chai Yue, PhD Candidate, School of Law, Tsinghua University. Visiting Researcher,
University of Pennsylvania Law School.
1 Electronic Cigarette Statistics, STAT. BRAIN RES. INST. (Mar. 2, 2016), http://www.
statisticbrain.com/electronic-cigarette-statistics/; Martinne Geller, Special Report: When It
Comes to E-cigs, Big Tobacco Is Concerned for Your Health, REUTERS (Mar. 23, 2015),
http://www.reuters.com/article/2015/03/23/us-ecigarettes-regulations-specialreportidUSKBN0MJ0GN20150323.
2 Yan Dingfei (严定非), Dianzi Yan: Silue Zai Wuzhu Zhi Di (电子烟:肆虐在无主之
地) [E-cigarettes Are Raging in No Man’s Land], SOUTHERN WEEKEND (Mar. 24, 2015),
http://www.infzm.com/content/102764.
†
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health, and the lack of quality control provisions governing the
electronic cigarette manufacturing process. More generally, tobacco
control measures targeted at combustible cigarettes should be
strengthened to better control combustible tobacco consumption and
address the increased use of e-cigarettes. Priority should be placed
on regulating sales to youth.
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The global electronic cigarette industry has exploded in the
past decade—from $20 million in sales in 2008 to an estimated $7
billion in 2014—and China has been an essential part of that growth.3
A Chinese chemist in 2003 developed the first e-cigarette, and China
quickly emerged as the world’s largest manufacturer of e-cigarettes,
currently responsible for over 90% of global e-cigarette production.4
As the world's largest consumer of combustible tobacco products,
accounting for about one-third of the global market, China is also a
prime contender to become the largest consumer of electronic
3 Electronic Cigarette Statistics, STAT. BRAIN RES. INST. (Mar. 2, 2016),
http://www.statisticbrain.com/electronic-cigarette-statistics/; Martinne Geller, Special
Report: When It Comes to E-cigs, Big Tobacco Is Concerned for Your Health, REUTERS (Mar.
23, 2015), http://www.reuters.com/article/2015/03/23/us-ecigarettes-regulations-special
report-idUSKBN0MJ0GN20150323.
4 Most e-cigarettes are manufactured in Shenzhen Provence. The Chinese electronic
cigarette market is expected to reach 9.6 billion Yuan in three years, according to the
Engineering Institute of the lithium battery industry, a private think tank with a focus on
strategic emerging industries in China. Dianzi Yan Shichang San Niannei Guimo Jiang Da
96 Yi Yuan (电子烟市场三年内规模将达 96 亿元) [The Electronic Cigarette Market Is
Expected to Reach 9.6 Billion Yuan in Three Years], GAOGONGLI DIAN ( 高 工 锂 电 )
[ENGINEERING INSTITUTE OF THE LITHIUM BATTERY INDUSTRY] (Dec. 3, 2013),
http://www.gg-lb.com/asdisp2-65b095fb-11448-.html.
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cigarettes. These simple facts raise a critical question—what should
the Chinese government do about regulating electronic cigarettes?
So far, the regulation of electronic cigarettes in China has
attracted scant attention. 5 This paper begins to fill that gap by
identifying the key issues confronting regulators in China and
suggesting a way forward. It first describes the origin and
development of e-cigarettes in China and then discusses the current
regulatory status of e-cigarettes. Because two of the key regulatory
options Chinese regulators are likely to consider—treating electronic
cigarettes as tobacco products or as pharmaceutical products—
represent the approaches of the United States and Japan respectively,
the paper discusses e-cigarette regulation in those countries and
analyzes its (relevance to China. The paper concludes by suggesting
that regardless of whether Chinese regulators decide to treat ecigarettes as tobacco products or pharmaceuticals, there are a number
of areas that invite immediate regulatory action. They include the
dubious health claims made by many e-cigarette companies, such as
suggesting that e-cigarettes are good for one’s health, and the lack of
quality control provisions governing the electronic cigarette
manufacturing process. More generally, tobacco control measures
targeted at combustible cigarettes should be strengthened to better
control combustible tobacco consumption and address the increased
use of e-cigarettes. Priority should be placed on regulating sales to
youth.
We are attentive to the fact that e-cigarette regulation in China
will be shaped to some degree by the nation’s high rate of
combustible tobacco consumption, the economic importance of
tobacco as a source of tax revenue, and the public health
consequences of its high smoking rate. Public health policy always
involves both predictions and tradeoffs, and government regulators
will have to assess the potential costs and benefits of more or less
aggressive e-cigarette regulation. Nonetheless, we argue in this paper
that continued regulatory inaction is not viable. It is time for China—
like the United States, Japan, the EU, and many other jurisdictions—
to engage e-cigarettes and craft a regulatory strategy, even one that is
likely to be imperfect.

5

Yan Dingfei (严定非), Dianzi Yan: Silue Zai Wuzhu Zhi Di (电子烟:肆虐在无主之
地) [E-cigarettes Are Raging in No Man’s Land], SOUTHERN WEEKEND (Mar. 24, 2015),
http://www.infzm.com/content/102764.
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THE ORIGIN AND DEVELOPMENT OF E-CIGARETTES IN
CHINA

In 2003, Han Li (韩力 ), a pharmacist from the Liaoning
Chinese Medicine Research Institute, obtained a patent for “A
Flameless Electronic Atomizing Cigarette.”6 Later named “RuYan”
(如烟), which in Chinese is evocative of a romantic ephemerality,7
the first e-cigarettes hit the market in China in 2004, with exports by
the Golden Dragon Group of Hong Kong starting the following year.
RuYan was quickly copied by new companies that entered the ecigarette market.
Although the products were eventually
differentiated by shape, color, and size, all of them used the same
basic technology, consisting of a prefilled or refillable cartridge
containing liquid nicotine and other ingredients (e-liquid), an
atomizer, a heating element, and a battery.8 Inhaling on an e-cigarette
heats the e-liquid and creates vapor, which mimics the effect of
smoking traditional tobacco products.
In recent years, e-cigarette consumption in China has
increased rapidly. 9 According to the China Domestic E-cigarette
Market Analysis, an industry report published in November 2014, the
average rate of e-cigarette use was 3.4% among smokers in five
representative cities including Beijing, Shanghai, Xi’an, Guangzhou

6

Yi Zhong Fei Keranxing Dianzi Wu Hua Xiangyan (一种非可燃性电子雾化香烟) [A
Flameless Electronic Atomizing Cigarette], China Patent No. 031111734 (filed Mar. 14,
2003), http://cpquery.sipo.gov.cn/txnQueryBibliographicData.do?select-key:shenqingh=03
1111734&select-key:backPage=http%3A%2F%2Fcpquery.sipo.gov.cn%2FtxnQuery
OrdinaryPatents.do%3Fselect-key%3Ashenqingh%3D031111734%26select-key%3
Azhuanlimc%3D%26select-key%3Ashenqingrxm%3D%26select-key%3Azhuanlilx%3D
%26select-key%3Ashenqingr_from%3D%26select-key%3Ashenqingr_to%3D%26innerflag%3Aopen-type%3Dwindow%26inner-flag%3Aflowno%3D1442572578938&innerflag:open-type=window&inner-flag:flowno=1442572597279.
7 The name “RuYan,” meaning “just like tobacco/smoke,” was carefully chosen.
Characters named RuYan appear in various romantic novels, songs, and movies thick with
nostalgia for the “good old days,” and there is an elegant fictional female character called
Miss RuYan who appears in various media.
8 They are also now differentiated by name, with some called e-cigarettes, others
vaporizers, and still others vaping pens or e-hookahs.
9 China Central Television, for example, reported in 2015 that the consumption of ecigarettes was booming and sales were increasing annually. Dianzi Yan Qinru Xiaoyuan
Shou Xuesheng Zhuipeng, Yizhi Nigu Ding Shangying (电子烟“侵入”校园,易致尼古丁
上瘾) [E-cigarettes "Invade" the Campus and Are Popular Among Students], CCTV NEWS
(May 7, 2015), http://m.news.cntv.cn/2015/05/07/ARTI1430961909196900.shtml.
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and Harbin.10 E-cigarettes use among minors has also taken hold. A
May 2014 survey by the Chinese CDC indicated that of 155,117
junior high school students (age 13–15) across 31 provinces, 45% had
heard of e-cigarettes, and 1.2% had used them in the past thirty
days.11 The use of e-cigarettes among youth has been noted by the
mass media, with one news report focusing on the sale of e-cigarettes
as toys at the entrance of a primary school and others describing the
preference for fruit flavors among youth and the concerns of parents
about their children who use e-cigarettes.12
Market data also tell a story of increased e-cigarette
consumption. In 2013, with a growth rate of 150%, China’s domestic
e-cigarette market reached ¥ 3.5 billion.13 In 2014, the market also
witnessed a growth spurt, with both sales and the number of users
increasing by 263% and 259% respectively over the previous year.14
Over the next five to ten years, according to industry researcher Xia

10

However, the sample size was quite small (500 people in each city). Clearly, more
data are needed. Dianzi Yan Guonei Shichang Fenxi (电子烟国内市场分 析) [China
Domestic E-cigarette Market Analysis], CECMOL (Nov. 14, 2014), http://www.cecmol.
com/news/show-3344.html.
11 2014 Zhongguo Qingshaonian Yancao Diaochao Baogao (2014 中国青少年烟草报
告) [China Youth Tobacco Survey], CHINESE CTR. FOR DISEASE CONTROL AND PREVENTION
(May 2015), http://www.tcrc.org.cn/UploadFiles/2015-07/251/2015070910174559651.pdf.
12 Hefei Yi Xiaoxue Menkou Dianziyan Dang Wanju Mai, Laoban Cheng Mei Weihai
(合肥一小学门口“电子烟”当玩具, 老板称没危害) [E-cigarettes Are Sold as Toys at
the Entrance of a Primary School, but the E-cigarettes Owner Asserts No Harm], ZHONG’AN
ZAIXIAN (Feb. 9, 2015), http://news.ifeng.com/a/20150209/43131134_0.shtml; Yizhong
Daiyou Guowei De Dianziyan Zai Xuesheng Zhong Liuxing Dan Weifa (一种带有果味的
“电子烟”在学生中流行但违法) [Fruit-Flavored E-cigarettes Popular Among Students],
NANTONG DAILY (Jan. 13, 2015), http://www.js.xinhuanet.com/2015-01/13/c_1113978067.
htm; Haizi Chou Dianziyan Ling Jiazhang Youxin, Zhuanjia: Cilei Shangpin Hui Wudao
Weichengnianren (孩子抽“电子烟”令家长忧心专家:此类商品会误导未成年人)
[Parents Are Concerned About Children Using E-cigarettes. Expert Said This Kind of
Product Will Misguide Minors], TAIZHOU EVENING NEWS (Jan. 28, 2015),
http://www.tznews.cn/2013/news/shehui/2015/01/2015-01-28220752.html.
13 Dianzi Yan Shichang San Niannei Guimo Jiang Da 96 Yi Yuan (电子烟市场三年内
规模将达 96 亿元) [The Electronic Cigarette Market Is Expected to Reach 9.6 Billion Yuan
in Three Years], GAOGONGLI DIAN (高工锂电) [ENGINEERING INSTITUTE OF THE LITHIUM
BATTERY INDUSTRY] (Dec. 3, 2013), http://www.gg-lb.com/asdisp2-65b095fb-11448-.html.
14 An interview by the China Medicine Economic Newspaper, sponsored by the China
Food and Drug Administration Southern Medicine Economic Institute, provides these
figures. Guonei Dianziyan Shichang Xushi Daifa (国内电子烟市场蓄势待发) [Domestic
Electronic Cigarette Market Is Ready], MED. ECON. NEWS (Jan. 19, 2015), http://www.
yyjjb.com/html/2015-01/19/content_219407.htm.
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Long, “the market compound growth rate will exceed 30%.” 15
Taobao, the largest online Business-to-Customer platform and an
important venue for the sale of e-cigarettes, 16 was the site of $22
million USD in sales of the top ten brands of e-cigarettes in 2014.17
Although the overall number of e-cigarette consumers in China and
gross sales are still relatively modest, analysts speculate that in the
upcoming decades, they will overtake the popularity of conventional
combustible cigarettes.18
Indeed, the potential market for such products in China is vast.
For every 1% rate of substitution of e-cigarettes for combustible
cigarettes, the Chinese e-cigarette market will increase by almost $5
billion USD.19 Moreover, China Tobacco (also known as the State
Tobacco Monopoly Administration) began to research and develop
its own e-cigarette product in 2013. In 2014, China Tobacco of Hubei,
a provincial subsidiary of the national tobacco monopoly China
Tobacco, launched its first series of e-cigarette products in Wuhan,
which marked China Tobacco’s formal entry into the e-cigarette
business.20
The involvement of China Tobacco in the e-cigarette business
is a significant event. As the government’s key tobacco-related
agency, it is responsible for almost all aspects of the tobacco industry,
including tobacco growth, production, sales, human resources,
finance, marketing, and trade. It includes thirty-three provincial
Tobacco Monopoly Administrations (provincial tobacco monopoly
subsidiary corporations), sixteen industrial companies, fifty-seven
cigarette industrial enterprises, more than 1,000 commercial

15

Dianziyan Zaoyu Binghuo Liangchongtian (电子烟遭遇冰火两重天) [E-cigarettes
Encounter Ice and Fire], TECH. DAILY (Sep. 2, 2014), http://scitech.people.com.cn/n/
2014/0902/c1007-25585378.html.
16 Woguo Dianzi Yan Hangye Shichang Zhuangkuang Fenxi (我国电子烟行业市场状
况分析) [Analysis of the E-cigarette Market in China], TIANYA.CN (May 20, 2014), http://
bbs.tianya.cn/post-141-628048-1.shtml.
17 Dianziyan Zaoyu Binghuo Liangchongtian, supra note 15.
18 See Zhongguo Ban Jinyanling Dianziyan You Shangji (中国颁禁烟令,电子烟有商
机) [China Bans on Combustible Cigarette, E-cigarette Will Have Business Opportunities],
SHENZHEN ECON. DAILY (Jan. 17, 2014), http://szsb.sznews.com/html/2014-01/17/content_
2756998.htm (stating that e-cigarettes are not very common in the Chinese market, but in
the next ten years, the sales of e-cigarettes will exceed the sales of ordinary cigarettes).
19 Dianziyan Zaoyu Binghuo Liangchongtian, supra note 15.
20 Mark O’Neill, How China is Lighting up the E-cigarette Market, EJINSIGHT (Aug. 11,
2014), http://www.ejinsight.com/20140811-china-e-cigartte/.
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enterprises, and over 510,000 employees.21 Additionally, more than
20 million people in China are directly linked to the tobacco industry,
including 1.3 million farming households and 5 million retailers, who
are all under the supervision of the Monopoly Administration.22 With
China’s massive government tobacco monopoly setting its sights on
the e-cigarette market, and the rapid growth of private sector
manufacturers (the number of e-cigarette enterprises more than
doubled in 2013), the use of e-cigarettes in China could become
staggering.23
The advertising and promotion of e-cigarettes in China, not
always truthful, has both contributed to their increased popularity and
illustrated the need for regulation. RuYan, for example, was
promoted as a lower-risk alternative to conventional cigarettes. The
manufacturer claimed that RuYan contained neither tar nor
carcinogens24 and that it qualified as a nicotine replacement therapy
that would enable smokers of combustible cigarettes to kick their
tobacco addiction.25 Other e-cigarette manufacturers, attentive to the
increasing social awareness about the health harm of combustible
tobacco products, have ignored the lack of data on the health impact
of e-cigarettes and marketed their products as "healthy,” “low harm,"
and "helpful to quit smoking."26
Because e-cigarettes are so new, scientists are still evaluating
their impact on public health. Studies are underway, but at this point
Zhongguo Yancao Hangye Gaikuang ( 中 国 烟 草 行 业 概 况 ) [Chinese Tobacco
Industry Overview], CHINA TOBACCO, http://www.tobacco.gov.cn/html/10/1004.html (last
visited Oct. 12, 2016).
22 Zhongguo Yancao Kongzhi Guihua [2012-2015] (中国烟草控制规划 [2012-2015
年]) [China Tobacco Control Plan (2012-2015)], CHINA TOBACCO, http://www.tobacco.
gov.cn/history_filesystem/2013yckz/ghqw2.htm (last visited Oct. 12, 2016).
23 According to the Engineering Institute of the lithium battery industry, a private think
tank with a focus on strategic emerging industries in China, the electronic cigarette market
is expected to reach 9.6 billion Yuan by 2018. GAOGONGLI DIAN, supra note 4.
24 The claim regarding the absence of tar is correct, but the absence of carcinogens is
more complicated. Most experts agree that e-cigarettes are significantly less carcinogenic
than combustible tobacco, but they also agree that e-cigarettes contain certain ingredients
that are carcinogenic.
25 Ruyan – Jiujing Shi Shenme Yan? (“如烟”－－究竟是什么“烟”?) [RuYan—
What Is RuYan After All?], PEOPLE’S DAILY (Dec. 18, 2006), http://news.xinhuanet.
com/life/2006-12/18/content_5503100.htm.
26 Li Baojiang (李保江), Zhongguo Yancao Zhongshui Zhengce dui Zengjia Zhengfu
Shouru he Jianxiao Yancao Xiaofei de Yingxiang (中国烟草重税政策对增加政府收入和
减少烟草消费的影响) [Effects of Increasing Tobacco Taxes on Government Revenue and
Consumption in China], 16 ACTA TABACARIA SINICA, no. 5, 2010, at 82.
21
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the only conclusion justified by the evidence is that no one knows
whether e-cigarettes are harmful to users or to bystanders. Nor is it
clear whether they will serve as a useful smoking cessation tool or
will be a gateway to the use of combustible cigarettes. As the World
Health Organization succinctly stated in a recent bulletin, “there are
only a few studies on the health risks and we don’t know the longterm effects; for now the evidence is inconclusive about whether
ENDS [electronic nicotine delivery systems, i.e., e-cigarettes] can be
an effective smoking cessation aid.” 27 A recent panel of experts
convened by the U.S. National Institute of Health similarly concluded
that the short-term and long-term effects of e-cigarettes on human
physiology and behavior are uncertain, and that there is very limited
data directly addressing whether e-cigarettes reduce combustible
tobacco consumption.28 In short, although e-cigarettes are a multibillion-dollar global industry, the scientific evidence regarding their
impact on individual and public health remains limited.
II.

REGULATORY INACTION OVER E-CIGARETTES IN CHINA

Despite the rapid growth of China’s e-cigarette industry and
the interest Chinese consumers have shown in e-cigarettes, the
manufacture, sale, and use of e-cigarettes in China remains largely
unregulated. Indeed, each of the agencies that might plausibly
exercise some regulatory control over e-cigarettes appears to be
studiously avoiding a leadership role. Their reluctance to engage the
regulation of e-cigarettes has been evident since RuYan appeared on
the market in 2006.
During a press conference held by the Ministry of Health
(now the National Health and Family Planning Commission) in May
2006, for example, a journalist from the China Daily asked whether
the Ministry would regulate RuYan as a smoking cessation product.29

27

Countries Vindicate Cautious Stance on E-cigarettes, 92 BULL. WORLD HEALTH ORG.
856, 856-857, WORLD HEALTH ORGANIZATION [WHO] (2014), http://www.who.int/bulletin/
volumes/92/12/14-031214/en/.
28 Kevin Walton et al., NIH Electronic Cigarette Workshop: Developing a Research
Agenda, 17 NICOTINE & TOBACCO RES. 259, 260 (2014).
29 Weishengbu “2006 Nian Zhongguo Xiyan Yu Jiankang Baogao” Fabuhui Neirong
Shilu – Kongyan Yu Fang’ai Fangzhi (卫生部《2006 年中国“吸烟与健康”报告》发布
会内容实录——控烟与防癌防治) [Press Conference Record of “Smoking and Health”
Report in 2006 by Ministry of Health—Tobacco Control and Prevention of Lung Cancer],
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The deputy director of the Maternal Child and Community Health
Division responded by saying that the main ingredient of RuYan was
nicotine, a product defined as a “dangerous chemical” that should be
regulated by the State Council under its Dangerous Chemicals
Regulations. 30 Moreover, the official continued, the regulation of
RuYan implicated a number of other ministries: the State
Administration of Work Safety was responsible for manufacturing
safety, the State Administration for Industry and Commerce was
responsible for advertising, and the Ministry of Health was
responsible for safety and toxicological tests. Together, in the
official’s view, these authorities were responsible for regulating ecigarettes.
That same year, China Tobacco echoed the view that RuYan
should be regulated under the State Council’s Dangerous Chemicals
Regulations, which distanced it from e-cigarette regulation. 31
Officials from other ministries were similarly evasive. In a series of
assertions reminiscent of Rashomon, those from the State
Administration of Work Safety stated: “It’s true that the production
and transportation of dangerous chemicals should be under our
supervision, however, a product which uses a dangerous chemical
and may cause harm to people should be regulated by other relevant
government authorities who are responsible for products. We’re
asking for instructions from our superior officials.” According to
officials from the Advertising Department in the State Administration
for Industry and Commerce, "Since the advertisement of RuYan is
not in the category of tobacco product, there is no requirement for
pre-approval by the agency. State Administration for Industry and
Commerce has noted related health concerns. So we’ve asked the
Ministry of Health, State Food and Drug Administration, and the
State Administration of Work Safety, to carry out identification
CHINA NAT’L HEALTH AND FAMILY PLANNING COMMISSION (May 29, 2006), http://
www.moh.gov.cn/wsb/pxwfb/200804/28081.shtml.
30 The Regulation has a number of general requirements applicable to the production,
storage, use, operation, and transportation of dangerous chemicals.
31 For the Three Ministries’ response to the RuYan issue, see San Bumen Jiu Ruyan
Wenti Zuochu Huiying, Ruyan Rengzai Miwu Zhong (三部门就“如烟”问题作出回应,
如烟仍在迷雾中) [Three Ministries Responded to "RuYan" Issue, and Ruyan Is Still in the
Mist], PEOPLE'S DAILY ONLINE (Dec. 1, 2006), http://politics.people.com.cn/GB/1027/
5116023.html (reporting that the manufacture and sales of RuYan shall be regulated under
dangerous chemicals regulations because RuYan contains nicotine, which is listed in the
dangerous chemicals checklist).
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testing.”32 Officials from the State Food and Drug Administration
stated that they had never approved any e-cigarette as either a
pharmaceutical product or a medical device. In June 2006, the
agency issued a document explicitly stating that nicotine electronic
vaporizers were used for eliminating smokers’ physiological needs
for nicotine and easing withdrawal symptoms, and that such devices
did not fit under the regulatory framework developed for medical
devices in China.33 RuYan had become the proverbial hot potato, and
no regulatory agency was willing to risk getting burned.
Almost ten years have passed since RuYan was brought to
market, and little regulatory progress has been made. As of May 2016,
no government agency in China has taken responsibility for
regulating e-cigarettes. Instead, as e-cigarettes grow in popularity
within and beyond China, and Chinese manufacturers continue to
produce most of the world’s e-cigarette devices, the relevant
government agencies seem anxious to make the regulation of ecigarettes someone else’s affair.
In the absence of regulations in China that treat e-cigarettes
as medical devices, pharmaceutical products, or tobacco products,
they are considered ordinary consumer products, subject to litigation
under the Product Quality Law34 and the Tort Liability Law.35 The
Product Quality Law,36 enacted in 1993, includes general provisions
that govern the manufacturing process, including product labeling
requirements, product adulteration, and counterfeit products. The
2010 Tort Liability Law 37 includes specific product liability
32

Id. (stating that if RuYan is identified as a tobacco product or tested toxic, the agency
will definitely ban advertising; if the company continues to advertise, the agency will
investigate and deal with it according to relevant laws).
33 For the applicable government notice that is administratively binding, see Guanyu
Baixibao Huisheng Xitong Deng Chanpin Fenlei Jieding De Tongzhi (关于白细胞回升系
统等产品分类界定的通知) [A Notice About the Product Classification of Recovery System
of Leukocytes] (promulgated by China Food and Drug Administration, June 18, 2006), art.
41, http://www.sfda.gov.cn/WS01/CL0845/10571.html.
34 Zhonghua Renmin Gongheguo Zhipin Pinzhi Fa (中华人民共和国制品品质法)
[Product Quality Law of the People's Republic of China] (promulgated by the Standing
Comm. Nat’l People's Cong., Feb. 22, 1993, effective Sept. 1, 1993, amended by the
Standing Comm. Nat’l People's Cong. on July 8, 2000), http://www.npc.gov.cn/wxzl/wxzl/
2000-12/05/content_4578.htm (China).
35 Zhonghua Renmin Gongheguo Qinquan Zeren Fa (中华人民共和国侵权责任法)
[Tort Liability Law of the People's Republic of China] (promulgated by the Standing
Comm. Nat’l People's Cong., Dec. 26, 2009, effective July 1, 2010), http://www.gov.cn/
flfg/2009-12/26/content_1497435.htm.
36 Product Quality Law, supra note 34.
37 Tort Liability Law, supra note 35.
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provisions, as well as other provisions that enable consumers to sue
for personal injuries. Although it may be sensible to treat e-cigarettes
as ordinary consumer products in a tort law context, that approach
cannot substitute for public health regulation. If e-cigarettes pose
health risks that can endanger users and bystanders, ex post tort
remedies are likely to fail to achieve the appropriate level of public
health protection. Moreover, tort litigation imposes a significant cost
on plaintiffs, both in terms of time and money, and could result in
limited or no compensation due to the large number of small and
possibly undercapitalized e-cigarette manufacturers.
The rising popularity of e-cigarettes in China and the
country’s dominance as a global e-cigarettes producer make China’s
regulatory paralysis particularly troubling as a matter of global public
health. Chinese children can purchase e-cigarettes with ease, eliquids are widely available in different flavors and with varying
quantities of nicotine, the public use of e-cigarettes is unrestricted,
and manufacturing standards are extremely weak. These concerns
have not been entirely lost on the media. Indeed, in 2011 the People's
Daily Online noted, “there are large numbers of counterfeit ecigarette products on the market with little safety guarantee, the
industry in China is in chaos.” 38 Recent articles in the Southern
Weekend and The New York Times have also highlighted the absence
of e-cigarette regulations in China, the lack of quality control
standards, the existence of heavy metals in e-cigarettes, and the risk
of exploding products.39
What, then, should be done? Should e-cigarettes be regulated
aggressively and kept out of the hands of consumers? Or, given the
well-known and profoundly negative impact of combustible tobacco
products on public health, should e-cigarettes be regulated more
modestly, with the hope that they will reduce the use of conventional
cigarettes and thus improve public health? In short, should Chinese

38

See Dianziyan HangyeLuanxiang Dai Bian (电子烟行业乱象待“变”) [The Ecigarette Industry’s Chaos Are Waiting for Changes], PEOPLE'S DAILY ONLINE (Dec. 14,
2011), http://finance.people.com.cn/stock/GB/222942/16603305.html
39 David Barboza, China’s E-Cigarette Boom Lacks Oversight for Safety, N.Y. TIMES
(Dec. 13, 2014), http://www.nytimes.com/2014/12/14/business/international/chinas-ecigarette-boom-lacks-oversight-for-safety-.html; Xinxingyan Dingxing Buming, Baiwan
Shichang Wu Jianguan (新型烟定性不明,百亿市场无监管) [Unknown Classification of
the New E-cigarettes Left Ten Billion Yuan Market Unregulated], SOUTHERN WEEKEND
(Aug. 1, 2014), http://www.infzm.com/content/102764.
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regulators embrace the precautionary principle, or is harm reduction
the better approach?
To make that determination, it is instructive to look at how
other nations are regulating e-cigarettes. Indeed, Chinese regulators
have recognized both the practical and rhetorical power of invoking
foreign models, pointing to how other nations are regulating ecigarettes in order to support their domestic policy preferences. 40
Two examples are particularly illuminating; the United States, which
issued regulations in May 2016 that treat e-cigarettes as tobacco
products, and Japan, which is regulating them as pharmaceutical
products. As the old Chinese proverb goes, “there are other hills
whose stones are good for working jade.” In addressing the question
of e-cigarette regulation, Chinese policy makers should be aware of
what regulators elsewhere are doing as they move toward developing
their own regulations.
III.

E-CIGARETTE REGULATION IN THE U.S. AND JAPAN
A.

United States

The U.S. e-cigarette saga began in October 2008, when the
FDA detained an inbound shipment of electronic cigarettes at the Los
Angeles International Airport. 41 Two companies, NJOY and
Smoking Everywhere, were importing the e-cigarettes from China
with the intention of selling them in the United States, but the FDA
thwarted their plans by claiming that nicotine-containing e-cigarettes
could not enter the United States without FDA approval. In the
FDA’s view, nicotine was a drug as defined in the Food, Drug, and
Cosmetic Act (FDCA), and e-cigarettes therefore had to be evaluated
by the FDA for safety and efficacy, like all drugs marketed in the
40 Li Baojiang (李保江), Quanqiu Dianziyan Shichang Fazhan, Zhuyao Zhengyi ji
Shichang Guanzhi (全球电子烟市场发展,主要争议及政府管制) [A Global Perspective
on the Future Development of Electronic Cigarettes and Related Controversial and
Regulatory Issues], 20 ACTA TABACARIA SINICA, no. 4, 2014, at 101, 101.
41 See FDA Fighting for Authority to Regulate Electronic Cigarettes, AM. ACAD.
FAMILY PHYSICIANS (Mar. 2, 2010), http://www.aafp.org/news/health-of-the-public/
20100302e-cig-fda.html (detailing the FDA’s appeal to regulate e-cigarettes as drug delivery
devices, rather than as tobacco products and providing background on the FDA’s detainment
of e-cigarette shipments at the Los Angeles Airport); Electronic Cigarettes and the FDA,
ELECTRONIC CIGARETTE SPOT, http://electroniccigarettespot.com/book/export/html/9 (last
visited Feb. 20, 2015).
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United States. 42 According to FDA Commissioner Margaret
Hamburg, “[t]he FDA is concerned about the safety of these products
and how they are marketed to the public.”43
Not surprisingly, e-cigarette importers aggressively fought
back. In their view, e-cigarettes could not be regulated under the
FDCA unless therapeutic claims were made on their behalf, such as
their utility as smoking cessation aids. Since importers had not made
such claims, they argued that their products did not fall within the
FDA’s jurisdiction over pharmaceutical products. Instead, they
insisted that the FDA could only regulate e-cigarettes under its
authority to regulate tobacco products, an authority that Congress had
only recently granted to the agency.44 Importers demanded that the
FDA put a halt to the detention of their products, and sued the FDA
in the D.C. Circuit Court.45
U.S. District Court Judge Richard Leon’s ruling in the case,
later affirmed on appeal, offered a sharp rebuke to the FDA’s position
and provided the plaintiff e-cigarette companies, and the e-cigarette
industry more generally, an open door to the cultivation of a U.S.based e-cigarette market.46 In Judge Leon’s view, the FDA could
only regulate e-cigarettes as drugs or drug delivery devices if they
were marketed with claims about their therapeutic effects. 47 In all
other cases, he ruled, the FDA could only regulate e-cigarettes by
invoking its jurisdiction over tobacco products.48
The District Court’s opinion, affirmed on appeal, left the FDA
in a difficult position. The U.S. Tobacco Control Act defines
“tobacco product” as any product “made or derived from tobacco”
that is not a “drug,” “device,” or combination product under the Act.
42

21 U.S.C. § 360d (1938).
Food and Drug Administration, FDA and Public Health Experts Warn About
Electronic Cigarettes, U.S. FOOD AND DRUG ADMIN. (July 22, 2009), http://www.fda.gov/
newsevents/newsroom/pressannouncements/ucm173222.htm.
44 See Tobacco Control Act, U.S. FOOD AND DRUG ADMIN., http://www.fda.gov/
TobaccoProducts/GuidanceComplianceRegulatoryInformation/ucm298595.htm
(last
visited Feb. 23, 2015) (describing how the Tobacco Control Act of 2009 gives the FDA
broad authority to regulate the manufacture, distribution, and marketing of tobacco products).
See also Family Smoking Prevention and Tobacco Control Act, Pub. L. No. 111-31, 123
Stat. 1776 (2009).
45 Smoking Everywhere, Inc. v. FDA, 680 F. Supp. 2d 62, 72 (D.D.C. 2010), aff’d sub
nom; Sottera, Inc. v. Food & Drug Admin., 627 F.3d 891 (2010).
46 Id.
47 Id. at 72–75.
48 Id. at 77.
43
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It permits the FDA to regulate conventional tobacco products as well
as other tobacco products that the Agency “by regulation deems to be
subject to the law.” The language is convoluted, but the direction is
clear: the FDA must first bring e-cigarettes into its regulatory orbit
by “deeming” them to be “tobacco products;” it can then regulate
them as it sees fit, so long as its specific regulations do not run afoul
of the Act.
In April 2014, more than four years after the District Court’s
decision, the FDA announced that it would extend its regulatory
authority over tobacco to e-cigarettes and other “tobacco products,”
such as cigars and hookah.49 Under the FDA’s proposed regulations,
e-cigarette manufacturers will be required to provide the FDA with a
list of product ingredients, submit all “new” products for FDA review,
refrain from claims about the reduced risk posed by their products,
and not distribute free samples.50 The FDA will also apply three key
tobacco control regulations to e-cigarettes: age restrictions on sales,
health warnings on packs, and limitations on vending machine
sales.51
As with all proposed agency regulations in the United States,
the FDA was required to publish its proposed regulations in the
Federal Register and seek public comment. In a clear sign of the
extraordinarily high degree of public and corporate interest in the
FDA’s approach to e-cigarettes, the publication of the FDA’s
deeming regulations garnered over 135,000 comments. The FDA
spent two years reviewing those comments, and in May 2016
announced a Final Rule that fundamentally reaffirms the provisions
contained in the proposed regulations.52
Three important points emerge from the U.S. experience.
First, the government had a clear preference for regulating e49

Heidi Ledford, FDA Proposes Regulation of Electronic Cigarettes, NATURE (Apr. 24,
2014), http://www.nature.com/news/fda-proposes-regulation-of-electronic-cigarettes-1.151
05.
50 Id.
51 Id.
52 Deeming Tobacco Products To Be Subject to the Federal Food, Drug, and Cosmetic
Act, as Amended by the Family Smoking Prevention and Tobacco Control Act; Restrictions
on the Sale and Distribution of Tobacco Products and Required Warning Statements for
Tobacco Products, 81 Fed. Reg. 28,973 (May 10, 2016). During the FDA’s long period of
inaction, many states and municipalities stepped into the breach and enacted a wide variety
of local e-cigarette controls, such as purchasing age limits, and public and/or work place
bans.
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cigarettes as pharmaceutical products; treating them as tobacco
products came at the insistence of the court, and was not the FDA’s
regulatory strategy. Second, having been forced by the court to
regulate e-cigarettes as tobacco products, the FDA has crafted a
precautionary policy that imposes a number of restrictions on ecigarettes and could (depending upon subsequent regulatory
interpretation and implementation) significantly limit the availability
of e-cigarettes.53 Third, in the absence of sufficient data about the
health risks of e-cigarettes and about whether e-cigarettes are more
likely to be a gateway to the use of combustible tobacco products or
an effective NRT, the FDA’s approach has been criticized as both too
restrictive and too lax.
B.

Japan

The Ministry of Finance has long held the legal authority to
regulate tobacco products in Japan, and it continues to be the
controlling shareholder of Japan’s only tobacco corporation, Japan
Tobacco.54 Article 1 of the Tobacco Business Law, which governs
Japan’s tobacco industry and articulates its tobacco policy, highlights
the importance of “promoting the sound development of the Japanese
tobacco industry, thereby securing national revenues.” 55 Political
support by the agricultural sector (within which tobacco farmers have
been influential) for Japan’s long-dominant political party, the
Liberal Democratic Party, has muted political support for regulations
that might decrease domestic tobacco consumption and sharpen the
regulatory strategy toward tobacco products. 56 Perhaps not
surprisingly, the Ministry of Health, Labor and Welfare (MHLW) has
limited power when it comes to tobacco control, which further helps
53 Among the important issues that will be clarified over the next two years is the
number of e-cigarette products that the FDA will determine to be “substantially equivalent”
to products marketed in the United States prior to February 15, 2007, which enables such
products to avoid the potentially costly and time-consuming process of pre-market
authorization.
54 Eric A. Feldman, The Landscape of Japanese Tobacco Policy: Law, Smoking and
Social Change, 49 AM. J. COMP. L. 679, 681–682 (2001).
55 Tabako Jigyō Hō (たばこ事業法) [Tobacco Business Act], Law No. 68 of 1984
(Japan).
56 See Eric A. Feldman, The Culture of Legal Change: A Case Study of Tobacco
Control in 21st Century Japan, 27 MICH. J. INT’L L. 743, 746–747 (2006) (analyzing how
the political economy of tobacco in Japan explained the absence of laws involving tobacco
consumption).
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to explain Japan’s weak of tobacco control policies. Given this
institutional history, the question raised by e-cigarettes in Japan is
whether the Ministry of Finance will regulate them as tobacco
products or the Ministry of Health, Labor, and Welfare will treat them
as pharmaceutical products.
In early December 2010, the MHLW announced that the
Pharmaceutical Affairs Law would be applied to e-cigarettes.
According to the Ministry, Article 2 of the 1984 Tobacco Business
Act defines a “tobacco product” (製造たばこ) as a product that is
constituted in whole or in part of tobacco leaves and is capable of
being smoked, chewed or sniffed.57 In turn, “tobacco leaf” (葉たば
こ) is defined as the leaf of a tobacco plant, and a “tobacco plant” (た
ばこ) is a plant of the nicotiana genus (タバコ属). That definition,
according to the MHLW, makes clear that e-cigarettes vaporizing a
nicotine-containing liquid are not tobacco products and cannot be
regulated as such. Instead, according to the MHLW, e-cigarettes, like
other products that contain nicotine, should be regulated under the
Pharmaceutical Affairs Law. On December 27, 2010, the MHLW
ordered local governments (prefectures and municipalities) to
monitor the sale of e-cigarettes containing nicotine, to prohibit
pharmacies from selling them, and to recall all nicotine-containing ecigarettes.58 The result is a de facto ban on e-cigarettes, at least until
an e-cigarette company seeks regulatory approval from the MHLW
on the basis that its product is safe and effective.
There is, however, a wrinkle on the regulatory fabric. The
MHLW’s approach was aimed at e-cigarettes that vaporize nicotinecontaining liquid. Some electronic cigarettes, however, vaporize
tobacco leaf, not liquid. Instead of being regulated as pharmaceutical
products by the MHLW, such vaporizers qualify as tobacco products
(since they contain tobacco leaf) and are regulated by the Ministry of
Finance. 59 From a public health perspective, there is little
justification for such a regulatory divide. There is no evidence that
leaf vaporizers pose fewer health concerns than liquid vaporizers, and
57

Tobacco Business Act, supra note 55.
Nikochin wo Ganyusuru Denshi Tabako ni Kansuru Kigai Boshi Sochi ni Tsuite (ニ
コチンを含有する電子タバコに関する危害防止措置について) [Harm Prevention
Measures Related to Electronic Cigarettes Containing Nicotine], JAPAN MINISTRY OF
HEALTH, LABOR AND WELFARE (Dec. 27, 2010), http://www.mhlw.go.jp/stf/houdou/2r98520
00000zlvf.html.
59 Interviews with officials at the Japanese Ministry of Finance and the Ministry of
Health, Labor and Welfare (Dec. 2014) (on file with author).
58
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one can speculate that because tobacco leaf contains over seventy
known carcinogens and leaf vaporizers operate at higher heat than
liquid vaporizers, they may pose greater health risks. But data are not
the primary concern when it comes to tobacco control in Japan.
Perhaps it is only a coincidence that Japan Tobacco did not have a
liquid-vaporizing e-cigarette in its product line but had made a
significant investment in a leaf vaporizer that it was ready to bring to
the Japanese market. Nonetheless, a regulatory strategy that imposes
a de facto ban on liquid vaporizers and enables the sale of leaf
vaporizers appears to satisfy the economic, political, and institutional
interests that have long animated tobacco policy in Japan and
maintained a powerful alliance between the Ministry of Finance,
Japan Tobacco, and other key players.
C.

The US and Japanese Approaches to E-Cigarette
Regulation: Implications for China

What lessons, if any, do the U.S. and Japanese experiences
hold for China? At least three general points emerge from the
preceding analysis. First, e-cigarette regulation is likely to reflect
prior institutional arrangements. These include the legal definition of
pharmaceutical and tobacco products, regulatory policy and politics,
patterns of tobacco consumption and control, and the weighing of
economic, political and health considerations in the crafting of public
health policy. Second, as the U.S. courts have made clear, the claims
manufacturers make about e-cigarettes—that they are safe, for
example—may be a critical factor in how they are regulated. Third,
uncertainty about the nature of e-cigarettes—what they should be
called, how they work—has led regulators to treat them like their
most obvious analog, combustible cigarettes, even though they are
different in a variety of notable ways. Policymakers in the U.S. and
Japan have adopted different regulatory strategies, yet their
differences are more a reflection of domestic power relations and
politics than of reasoned policy analysis. Chinese policymakers can
benefit from understanding those differences, but they are left with
the difficult task of having to identify a workable regulatory approach
that is more attentive to public health than private and state profit.
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CHINA’S REGULATORY OPTIONS
A.

Legal Definitions

In considering China’s primary regulatory options—
regulating e-cigarettes as pharmaceutical or tobacco products—one
must first examine the relevant Chinese laws governing those
approaches.
Article 2 of the 1991 China Tobacco Monopoly Law,
modified in 2009, 2013, and 2015, defines “tobacco monopoly
products” as including cigarettes, cigars, pipe tobacco, re-dried
tobacco leaf, tobacco leaf, cigarette paper, cigarette filter rods, tow
for cigarette, and cigarette manufacturing equipment. It defines
“tobacco products” as cigarettes, cigars, pipe tobacco, and re-dried
tobacco leaf. 60 E-cigarettes do not naturally fit any of these
categories. For e-cigarettes to be folded into the Tobacco Monopoly
Law, the nicotine extracted from tobacco leaf (all tobacco leaf in
China is controlled by the Tobacco Monopoly Bureau) would itself
have to be legally defined as a ‘tobacco product.” In the absence of
such a redefinition or interpretation, e-cigarettes will remain beyond
the reach of China’s Tobacco Monopoly Law.
China’s Drug Administration Law, enacted in 1984 and
modified in 2001 and 2015, defines pharmaceutical products as
“articles which are used in the prevention, treatment and diagnosis of
human diseases and intended for the regulation of the physiological
functions of human beings, for which indications, usage and dosage
are established, including Chinese crude drugs, prepared slices of
Chinese crude drugs, traditional Chinese medicine preparations,
chemical drugs substances and their preparations, antibiotics,
biochemical drugs, radioactive pharmaceuticals, serum, vaccines,
blood products and diagnostic agents.“61 This definition establishes
three criteria for a product to be considered a drug: it must be “used
in the prevention, treatment and diagnosis of human diseases,” be
“intended for the regulation of the physiological functions of human
60 Yancao Zhuanmai Fa (烟草专卖法) [China Tobacco Monopoly Law] (promulgated
by the Standing Comm. Nat’l People’s Cong., June 29, 1991, effective Jan. 1, 1992, amended
Apr. 24, 2015), art. 2, http://www.tobacco.gov.cn/html/27/2701/270101/4830381_n.html.
61 Yaopin Guangli Fa (药品管理法) [China Drug Administration Law] (promulgated
by the Standing Comm. Nat’l People’s Cong., Feb. 28, 2001, effective Dec. 1, 2001,
amended Apr. 24, 2015), art. 102, http://www.npc.gov.cn/npc/cwhhy/12jcwh/2015-04/25/
content_1934604.htm.
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beings,” and have “established indications, usage and dosage.” Do
e-cigarettes fall under this definition? As in the United States, that
will at least in part depend upon the interpretation of the meaning of
intent, as well as on how e-cigarettes are advertised and promoted.
To the degree than Chinese e-cigarette corporations continue to
market their products as smoking cessation aids or as healthy
alternatives to smoking, they invite regulation under the Drug
Administration Law. But so far, regulators in that agency show no
sign of action.
Additionally, in the recently modified Regulations for the
Supervision and Administration of Medical Devices enacted by the
State Council, the definition of medical device emphasizes that a
“medical device’s principal action in or on the human body is not
achieved by means of pharmacology, immunology or metabolism.”62
This definition may preclude e-cigarettes, the utility of which
generally relies on the pharmacological efficacy of nicotine on human
metabolism.
In short, current legal provisions in China indicate that ecigarettes do not clearly fall under the definition of tobacco products,
pharmaceuticals, or medical devices. Regulating e-cigarettes in
China will thus inevitably involve amending existing legislation,
most likely by the Standing Committee of the National People’s
Congress or through a binding judicial interpretation from the
Supreme People's Court and the Supreme People's Procuratorate. If
such amendments are necessary, which types of amendments would
be most desirable?
B.

Regulating E-Cigarettes as Pharmaceutical Products

There are both theoretical and practical reasons to regulate ecigarettes as pharmaceuticals. Theoretically, the precautionary
principle invites the government, in the absence of sufficient
scientific evidence that establishes the safety of a product, to adopt a
relatively strict regulatory approach for the sake of public health.
Given the scientific uncertainty about e-cigarettes, keeping them off

62 The regulations make clear that a pharmacological, immunological or metabolic
impact must be a secondary, not primary, function.
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the market or strictly limiting their availability would seem a prudent
precautionary approach.63
Pragmatically, the fact that many manufactures in China
promote their products by asserting that e-cigarettes are less harmful
than combustible cigarettes and are helpful in smoking cessation also
calls for preemptive regulation. According to a content analysis of ecigarette manufacturers’ websites in China, health-related benefits
were claimed most frequently (89%), followed by claims of no
secondhand smoke exposure (78%) and utility for smoking cessation
(67%).64 A search of Taobao.com using “e-cigarette” (电子烟) as
the key word reveals that all twenty of the top e-cigarette products as
of May 2015 are promoted with claims about “smoking cessation" or
"harmlessness.” (See the promotional pictures from the top three
best-selling e-cigarettes on Taobao.com below.)65

Illustration 1. Title: XX E-cigarettes are popular everywhere. The six small signs
refer to hotels, hospitals, schools, offices, airports and restaurants. The caption
states: “XX e-cigarettes not only assist in smoking cessation, but also solve the
problem of smoking bans in public places like offices, schools, hospitals and
restaurants, since they do not produce second hand smoke.” 66

63 The precautionary approach in China is often discussed and has been adopted in
environmental law and marine environmental protection in recent years. See, e.g., Zhang
Luoping (张珞平), et al., Yujing Yuanze Zai Huanjing Guihua Yu Guanli Zhong de Yingyong
(预警原则在 环境规划 与管理 中的应用) [Application of Precautionary Principle in
Environmental Planning and Management], 43J. XIAMEN UNIV. (NATURAL SCIENCE) 221,
221 (2004) (discussing the precautionary principle and its application in environmental
planning and management).
64 Tingting Yao et al., A Content Analysis of Electronic Cigarette Manufacturer
Websites in China, 25 TOBACCO CONTROL 188, 188 (2016).
65 Even Judge Richard Leon, whose opinion in the e-cigarette litigation made clear his
distaste for government regulation, would have little trouble accepting the need for
government regulations in the face of such unsubstantiated health claims.
66 Downloaded from https://www.taobao.com (May 30, 2015).
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Illustration 2. Eight significant reasons to buy e-cigarettes. The eight reasons as
shown in the small pictures include no tobacco ash, no tar, various flavors, trendy
and fashionable, assist in smoking cessation, effective smoking cessation, no
second hand smoke, and portable.67

67

Id.
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Illustration 3. Certificate of guarantee. Many sellers assert that their products have
been examined and/or approved by domestic and international institutions, like the
CDC in China and the FDA in the U.S. The picture displays certificates one seller
claims to have received for its e-cigarettes.68

For Chinese policymakers to treat e-cigarettes as
pharmaceuticals, the current legal definition of drugs will have to be
modified. Such modification may be on the way. The Chinese Drug
Administration Law, part of the National People’s Congress
legislative reform program, is now being revised by the Chinese Food
and Drug Administration and is expected to be completed before
March 2018. Some scholars have proposed that the CFDA should
have the discretion to decide which substances should be deemed
pharmaceutical products, in order to establish “the most stringent
drug regulatory system” required by the Premier. Indeed, the public
online database of the CFDA includes twenty-four nicotine-based
drugs for nicotine replacement therapy (twenty-two imported and two
domestic) divided into five categories, including chewing gum,
patches, transdermal agents, active pharmaceutical ingredients, and

68

Id.
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sublingual tablets.69 Clearly, some nicotine products in China have
already been placed under the CFDA’s domain.
If the CFDA is granted regulatory control of e-cigarettes,
companies will be required to submit product applications with
information on clinical trial data, product ingredients, dosage, and
more. An expert panel within CFDA will evaluate product safety,
efficacy and other relevant indicators and make a decision about
product approval. Manufacturers, suppliers, and users will then be
subject to a variety of supervision and inspection rules, such as the
Good Manufacturing Practices in accordance with the Chinese Drug
Administration Law. 70 Ultimately, the CFDA could issue detailed
standards for e-cigarettes. Although high product quality is not
produced merely by strict government regulation, a relatively strict
review, approval, and supervision system can benefit consumers by
providing at least better quality products. In addition, existing
pharmaceutical laws and regulations, such as drug labeling
requirements, will apply to e-cigarettes and will help keep consumers
informed.
There are, however, some potential costs to regulating ecigarettes as pharmaceuticals.
First, for those e-cigarette
corporations not making health claims about their products, it may be
difficult to justify the imposition of pharmaceutical regulations. If
the presence of such claims invites regulation as a drug, surely the
absence counters such regulation. Second, there is a possibility that
e-cigarettes will turn out to be an effective nicotine replacement
therapy. However, accumulating data that show safety and efficiency
will take years, and during that time, many people’s health would be
harmed by combustible tobacco products. Finally, the Japanese
approach to regulating e-cigarettes as pharmaceuticals provides a
cautionary tale. Even more so than Japan, the Chinese government
retains a monopoly over the tobacco industry, and tobacco taxes and
profits constitute a considerable proportion of both central and local

69

The definition from China Drug Administration Law now decides what counts as a
drug. The CFDA has not been given the deeming power, i.e., defining a product as a drug
merely out of CFDA’s own discretion.
70 See, e.g., Zhonghua Renmin Gongheguo Yaopin Guanli Fa (中华人民共和国药品
管理法) [Drug Administration Law of the People’s Republic of China] (promulgated by
the Standing Comm. Nat’l People’s Cong., Sept. 20, 1984, amended Feb. 28, 2001), art. 9,
http://www.sda.gov.cn/WS01/CL0064/23396.html (China).
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government revenue.71 Even if e-cigarettes that contain nicotine are
brought under the control of the CFDA, products that vaporize
tobacco leaf could, as in Japan, be regulated by those responsible for
the lax regulation of combustible tobacco products—namely China
Tobacco, under the China Tobacco Monopoly Law. Such an
approach is unlikely to prioritize public health and could well lead to
similar problems as those experienced under China’s “double-track”
regulatory system in the food and drug area.72
C.

Regulating E-Cigarettes as Tobacco Products

Regulating e-cigarettes as tobacco products would sidestep
some of the potential problems inherent in the pharmaceutical
approach. Rather than justifying regulation by pointing to the
representations made by e-cigarette manufactures, a tobacco control
approach focuses on the public health consequences of e-cigarettes.
Such a focus would regulate liquid and leaf vaporizers similarly,
unless data on their public health impact counsel a different approach.
The most significant benefit of regulating e-cigarettes as tobacco
products will be realized if studies ultimately support the view that
the use of e-cigarettes reduces morbidity and mortality caused by the
use of combustible cigarettes. Chinese smokers currently consume
about one-third of all tobacco products smoked per annum globally,
and as a result, over 1 million Chinese die annually from tobacco-

71 In 2014, tobacco tax combined with profit reached 1 trillion Yuan, which constituted
over 6% of government revenue. 2015 Nian Quanguo Yancao Gongzuo Huiyi Xianchang
Shishi Baodao (2015 年全国烟草工作会议现场实时报道) [Live Report of the 2015
National Tobacco Conference], E. TOBACCO J. (Jan 15, 2015), http://www.eastobacco.
com/zxbk/wzzt/2015nqgycgzhuztbd/2015zbbd/201501/t20150114_354690.html;
2014
Nian Caizheng Shouzhi Qingkuang (2014 年 财 政 收 支 情 况 ) [2014 Fiscal Balance],
CHINESE GOV. NETWORK (Jan. 30, 2015), http://www.gov.cn/xinwen/2015-01/30/content_
2812441.htm. See also Li, supra note 26 (emphasizing the importance of tobacco tax and
profit to government revenue in China).
72 Previously, governance over food and drugs in China was divided between several
ministries, leading to an unclear division of responsibility among agencies. Problems with
food safety were generally attributed to such multiple governances. In March 2013, at the
beginning of the central government’s new term, it tried to create a unified and centralized
food and drug regulatory system. Guojia Shipin Yaopin Jianguan Zhongju Guapai Shipin
Jianguan Buzai “Jiulong Zhishui” (国家食品药品监管总局挂牌食品监管不再“九龙治
水”) [State Food and Drug Administration Established; Food Supervision Is No Longer
Responsibility-Diverse], XINHUA NEWS (Mar. 22, 2013), http://news.xinhuanet.com/201303/22/c_115125786.htm.
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related diseases. 73 Because regulating e-cigarettes as tobacco
products generally results in control rather than prohibition, it could
lead to the growing popularity of e-cigarettes, a drop in combustible
tobacco use, and an overall improvement in public health.
In order to regulate e-cigarettes as tobacco products, the
definition of tobacco products under the China Tobacco Monopoly
Law (the “CTML”) must be revised. Because the CTML is a national
code ratified by the Standing Committee of the National People’s
Congress, the State Tobacco Monopoly Administration (the agency
that manages the tobacco monopoly) is responsible for justifying the
need for a legal change and drafting revisions. Alternatively, drafting
a new law could be avoided if the Supreme People's Court and
Supreme People's Procuratorate issued a new judicial interpretation
of the law. Indeed, in 2013, the media reported that a new judicial
interpretation of the China Tobacco Monopoly Law would soon place
e-cigarettes under the tobacco monopoly system.74 However, no such
judicial interpretation has yet been presented.
In addition to the possibility that regulating e-cigarettes as
tobacco products could help reduce tobacco-related morbidity and
mortality in China, it also has significant financial implications for
the government. Tobacco monopoly income is a major source of
government revenue; tobacco taxes combined with profit constitute
over 6% of total government income. 75 At the regional level, a
tobacco leaf tax (tax rate is 20%) flows directly to local government,
together with 25% of the value-added tax (tax rate is 17%). 76 In
provinces like Yunnan and Guizhou, where tobacco is a pillar
73

See Zhongguo Yancao Kongzhi Guihua (2012-2015 Nian) (中国烟草控制规划
（2012-2015 年）) [China Tobacco Control Plan (2012-2015)], CHINA TOBACCO, http://
www.tobacco.gov.cn/history_filesystem/2013yckz/ghqw-more.htm (last visited May 10,
2016) (discussing a control plan for tobacco in China from the year 2012 to 2015).
74 See Niandi Guojia Youwang Chutai Yancao Zhuanmai Sifa Jieshi Han Dianzi Yan
(年底国家有望出台烟草专卖司法解释含电子烟) [Tobacco Monopoly Law Judicial
Interpretation Hopefully Could Be Issued by the End of the Year, Which Would Include
Electronic Cigarettes], PEOPLE.COM.CN (Dec. 4, 2013), http://js.people.com.cn/html/
2013/12/04/272979.html (discussing the possibility of issuance of a judicial interpretation of
the Tobacco Monopoly Law in China).
75 Li, supra note 26. The central government collects a tobacco excise tax, a valueadded tax, and a certain amount of net profit from the China National Tobacco Corporation.
76 Value-added tax is a kind of shared tax by central and local government in China.
The tax rate is 17%. Central government gets 75% of it, while local government gets 25%.
See Bu Wei, Zhongguo Difang Caizheng Dui Yancao Shuishou de Yilai (中国地方财政对
烟草税收的依赖) [The Dependence of Local Finance on Tobacco Tax in China], CNKI
(2014), http://cdmd.cnki.com.cn/Article/CDMD-80201-1014046237.htm.
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industry, the tobacco leaf tax is particularly important.77 Regulating
e-cigarettes as tobacco products would enable the Chinese
government to potentially collect a large sum of tax and profit.
Regardless of whether e-cigarettes turn out to be a gateway to or exit
from the use of combustible tobacco products, they would become a
significant generator of revenue for both the central and local
government.
Folding e-cigarettes into the government’s tobacco monopoly
also presents a number of challenges. By defining e-cigarettes as
tobacco products and asserting government control, the legal status
of hundreds of private e-cigarette factories and thousands of online
and brick and mortar retailers will be called into question. How, and
how quickly, could China Tobacco absorb those companies or issue
monopoly licenses? Moreover, China Tobacco faces a steep learning
curve in regulating e-cigarettes. So far, it has little experience in
regulating manufactures of vaporizers or e-liquids that contain
various amounts of nicotine. Doing so effectively requires research
and planning in terms of equipment, personnel, and more. In addition,
particularly given the large number of Internet-based sellers, effective
enforcement will be a challenge.
Finally, regulating e-cigarettes as tobacco products begs the
question of whether China has effectively regulated other tobacco
products. Unfortunately, the answer is no. Formally, China signed
the WHO’s Framework Convention on Tobacco Control in
November 2003, and ratified it in August 2005. In April 2007, the
State Council approved the establishment of the “FCTC
Implementation Inter-Ministerial Coordination Leading Group,” with
members from the National Health and Family Planning Commission,
State Tobacco Monopoly Administration, and other relevant
ministries.78 Under the leadership of that group, efforts have been
made to prohibit tobacco advertising in the mass media, ban tobacco

77

Id.

78See

Guowuyuan Guanyu Tongyi Chengli Yancao Kongzhi Kuangjia Gongyue Lvyue
Gongzuo Buji Xietiao Lingdao Xiaozu de Pifu (国务院关于同意成立烟草控制框架公约
履约工作部际协调领导小组的批复) [The State Council Agreed to Set up the FCTC
Implementation Inter-Ministerial Coordination Leading Group], CHINALAW.GOV.CN (Mar.
30, 2010), http://www.chinalaw.gov.cn/article/fgkd/xfg/fgxwj/201003/20100300251040.
shtml (discussing the setting up of the FCTC Implementation Inter-Ministerial Coordination
Leading Group and specifying the composition and functions of the group).
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use in indoor public places, and forbid sales to minors.79 Moreover,
under the China Tobacco Control Plan (2012-2015), more rigorous
measures such as prohibiting smoking in public places, strengthening
warnings on cigarette packets, and banning tobacco promotion and
sponsorship are on the way.
Nonetheless, tobacco control policy in China has long been
criticized as weak and poorly enforced.80 Per capita smoking rates
are high, second-hand smoke exposure is ubiquitous, youth access is
widespread, and public education is poor. Extending this weak
tobacco control regime to e-cigarettes is a troubling prospect. Further,
China Tobacco’s goal is to improve sales and make a profit, and it
has little interest in a more robust tobacco control policy. Indeed,
with an eye toward maximizing profit, one can easily imagine that
China Tobacco will be inclined to promote the still-unclear benefits
of e-cigarettes and minimize their potential risks.
V.

CONCLUSION

The explosion in the growth of the e-cigarette industry, the
popularity of e-cigarettes among consumers and their unclear impact
on public health make e-cigarette regulation in China a necessity.
While regulatory choices in the United States and Japan may be
instructive for Chinese regulators, in neither country has e-cigarette
regulation been free of controversy, and neither presents a readymade approach that can be applied to China. The Chinese
government can learn about e-cigarette regulation elsewhere and

79

The Smoking Control Ordinance of Shenzhen Special Economic Zone focused on
strengthening the enforcement of smoking-bans in public places. It created six municipal
agencies – Public Security Bureau, Urban Management Bureau, Transportation Commission,
Health Supervision Bureau, Sports and Tourism Bureau, and Market Supervision Bureau –
responsible for enforcing the Ordinance in their own domains. From March 1 to December
31, 2014, 100,253 public places were inspected and 8,675 people were administratively fined
a total of ¥ 420,100. Shenzhen, where the most aggressive smoking regulations were
implemented in 2014, is seen as a model tobacco control city in China.
80 See Hong Yu (洪宇), Zhongguo Kongyan Zhengce Bianqian: Jiyu Zhichi Lianmeng
Kuangjia de Fenxi (中国控烟政策变迁:基于支持联盟框架的分析) [The Change of China
Tobacco Control Policy: An Advocacy Coalition Framework-Based Analysis], 7.3 CHINESE
J. HEALTH POL’Y 20, 20 (2014) (analyzing the historical changes in Chinese tobacco control
policy). See also Jun Lv, et al., Implementation of the WHO Framework Convention on
Tobacco Control in Mainland China, 20 TOBACCO CONTROL 309, 309 (2011) (discussing
how China has implemented the WHO FCTC on tobacco).
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hopefully learn from those experiences. But it must craft its own set
of policies.
As Chinese policy makers ponder their approach to ecigarette regulation, they should consider taking immediate action in
several arenas. First, the dubious health claims made by many (most)
e-cigarette companies can and should be regulated under the China
Advertising Law. Promotional materials claiming that e-cigarettes
will help people stop smoking and touting their safety can mislead
consumers and harm public health. The Advertising Law, revised in
September 2015, includes several articles relevant to e-cigarette
regulation.81 Article 4 requires that “advertisements must not contain
false or misleading content and must not deceive or mislead
consumers.” 82 Article 17 states that “except for medical,
pharmaceutical, and medical device advertising, any other
advertising related to the treatment of disease is prohibited; medical
terms or other terms that may suggest that the product confused with
pharmaceutical or medical device are prohibited.” 83 In addition,
Article 28 defines false advertising as “false or misleading
advertising content to deceive or mislead consumers.”84 The State
Administration for Industry and Commerce is responsible for
enforcing the Advertising Law, which applies to all consumer
products. In doing so, it can inspect, survey, inquire, require relevant
certificates and documents, and demand the suspension of advertising.
Failure to adequately police adverting exposes the State
Administration for Industry and Commerce to potential legal liability.
Second, China is the world’s e-cigarette factory, but it lacks
adequate quality control standards. Such standards should cover (but
not be limited to) the raw materials used to manufacture e-cigarettes,
the microchips that are placed into e-cigarettes, the types of batteries
they use, the presence of heavy metals, and many other factors that
can lead to manufacturing defects, design defects, and consumer
harm. In addition, China produces a significant amount of e-liquid,
and that too is in need of quality controls that address the quality of
81 Zhonghua Renmin Gongheguo Guanggao Fa ( 中 华 人 民 共 和 国 广 告 法 )
[Advertising Law of the People's Republic of China] (promulgated by Standing Committee
of the Nat’l People’s Cong., Apr. 24, 2015, effective Sept. 1, 2015), http://www.gov.cn/
zhengce/2015-04/25/content_2853642.htm (China).
82 Id.
83 Id.
84 If e-cigarettes were legally defined as tobacco products or drugs, advertising would
require governmental review and approval. However, in the absence of a clear definition,
the State Administration for Industry and Commerce has justified regulatory inaction. Id.
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the concentration of nicotine, the use of additives, and types of
flavorings. Quality control provisions can come from a number of
sectors: industrial organizations can draft manufacturing codes of
practice; individual companies may seek quality certificates from
reliable third-party institutions; and government agencies such as the
General Administration of Quality Supervision, Inspection, and
Quarantine or the China Food and Drug Administration could
together issue standards.
Third, the regulation and use of e-cigarettes is inevitably tied
to the regulation of combustible tobacco. Pragmatism and public
health both counsel that tobacco control measures in China should be
strengthened as a precursor/companion to e-cigarette regulation. One
priority should be the regulation of underage sales. The Law on
Protection of Minors and the Law on Prevention of Juvenile
Delinquency both state that “no business places may sell cigarettes or
alcoholic drinks to minors.”85 The China Advertising Law prohibits
tobacco advertising to minors, and the China Tobacco Monopoly
Law discourages young people from smoking and forbids primary
and middle school students to smoke.86 However, according to China
National Radio, nearly half of all cigarette retailers do not post signs,
as required under the law, stating that they do not sell tobacco
products to minors, and middle school students can easily purchase
tobacco products in shops near their schools.87 A more robust ban,
with enforced legal penalties, would help limit tobacco consumption
in China and set a useful baseline for e-cigarette regulation. Other
tobacco control measures, such as packet warnings, taxation, and
bans on smoking in public places should also be pursued.
Enforcement must also be a key component of a more vigorous
tobacco control agenda.

85 Article 2 of the Law on Protection of Minors states that minors refers to citizens under
eighteen years old. Zhonghua Renmin Gongheguo Weichengnianren Baohu Fa (中华人民
共和国未成年人保护法) [Law on Protection of Minors of the People's Republic of China]
(promulgated by the Standing Comm. Nat’l People’s Cong., Sept. 4, 1991, effective Jan. 1,
1992), art. 2 (China).
86 A more explicit ban on sales of cigarettes to juveniles would help to limit tobacco
consumed in China, and would set a useful baseline for e-cigarettes.
87 See Diaocha Cheng Woguo Jinban Yandian Dui Weichengnian Bu Shefang (调查称
我国近半烟店对未成年不设防) [Survey Shows Nearly Half of Tobacco Retailer Shops in
China Take No Measures to Prevent Sales to Minors], CHINA.CNR.CN (June 25, 2015),
http://china.cnr.cn/qqhygbw/20150625/t20150625_518955879.shtml (discussing the facts
and reasons why many tobacco shops are undefended to minors).
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Finally, future e-cigarette regulation in China should pay
special attention to the impact and implication of China’s current
smoking epidemic. Tobacco consumption in China is extremely high,
tobacco control policies are weak, and there is no sign that smoking
rates in China are decreasing at a significant pace. This environment,
quite different than in the United States and Japan, may have
meaningful implications for future e-cigarette regulation. One
possibility is that e-cigarettes should be regulated less aggressively in
China than elsewhere because of the urgent need to lower tobacco
consumption rates. Harm reduction, in other words, may have greater
urgency in China, and that urgency may persuade policymakers to err
on the side of relatively permissive e-cigarette regulation. The
opposite approach may be equally persuasive; perhaps e-cigarettes
should be regulated aggressively because they could further
complicate or worsen China’s combustible tobacco consumption
problem. Whichever direction Chinese policymakers turn, they are
likely to discover what is already apparent to their counterparts in the
United States and Japan. No approach to e-cigarette regulation is
wholly satisfactory, but the worst approach is no approach at all.

